Organisation
Department of Pharmaceutics
Department
Current researchers
1 - 10 of 120 results
- Chris Vervaet (Responsible)
- Justine Aelvoet (Member)
- Ilke Aernout (Member)
- Amin Ahmad (Member)
- Mohsin Ali (Member)
- Ruben Almey (Member)
- Dominika Berdecka (Member)
- Danique Berrevoet (Member)
- Louis Bouckaert (Member)
- Kevin Braeckmans (Member)
Projects
1 - 10 of 375
- A platform for the fast development of thermostable lyophilized mRNA lipid nanoparticle (LNP) vaccinesFrom7 Feb 2024 → TodayFunding: Foreign private sponsor - undefined
- Getting picobodies out of their comfort zone - Investigating the in vitro affinity maturation, folding and structure of isolated picobodiesFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Unraveling the role of the immune system in the development of exuberant granulation tissue in horse woundsFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- Design and synthesis of inhibitors of the MEP pathwayFrom1 Jan 2024 → TodayFunding: BOF - doctoral mandates
- DEXTRACs: An innovative concept for targeted degradation of extracellular proteinsFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Uncaging the potential of photopharmacology for the treatment of epilepsyFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- LNP-DECODE: Deciphering the adjuvants activity of lipid nanoparticle-based mRNA vaccines in primary dendritic cellsFrom1 Jan 2024 → TodayFunding: BOF - projects
- Restoring fertility by the 3R-approach : rejuvenating, replacing or reconstructing the oocyteFrom1 Jan 2024 → TodayFunding: BOF - projects
- Evaluation of formulation parameters o n the mRNA integrity within mRNA lipid nanoparticlesFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
- Towards clinical testing of novel stabilized less toxic asparaginases for the treatment of acute lymphoblastic leukemiaFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
Publications
1 - 10 of 1921
- Tailored design of sugar-modified a-GalCer analogues for Th1-polarized immune responses(2018)
Authors: Serge Van Calenbergh
Pages: 42 - 42 - Structural basis for the recognition of C20:2-U+03B1GalCer by the invariant natural killer T-cell receptor-like antibody L363(2012)
Authors: Esther Dawen Yu, Enrico Girardi, Jing Wang, Thien-Thi Mac Mac, Karl OA Yu, Serge Van Calenbergh, Steven A Porcelli, Dirk M Zajonc
Pages: 1269 - 1278 - Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease(2014)
Authors: Maria Sabater-Lleal, Aners Mälarstig, Lasse Folkersen, María Soler Artigas, Damiano Baldassarre, Maryam Kavousi, Peter Almgren, Fabrizio Veglia, Guy Brusselle, Albert Hofman, et al.
- Outpatient Pharmacotherapy(2008)
Authors: Guy Brusselle
Pages: 331 - 349 - Properties of the COPD assessment test in a cross-sectional European study(2011)
Authors: PW Jones, Guy Brusselle, RW Dal Negro, M Ferrer, P Kardos, ML Levye, T Perez, JJ Soler Cataluña, T van der Molen, L Adamek, et al.
Pages: 29 - 35 - Mechanistic links between COPD and lung cancer: a role of microRNA let-7?(2014)
Authors: Jae Il Shin, Guy Brusselle
Pages: 70 - 70 - Effect of a 3-month low-dose azithromycin intervention for COPD exacerbations requiring hospitalization on subsequent respiratory events and mortality : the BACE trial(2019)Volume: 199
Authors: W Janssens, K Vermeersch, T Troosters, Guy Brusselle
Number of pages: 1 - Disease-modifying anti-asthmatic drugs(2022)
Authors: Marek Lommatzsch, Guy Brusselle, G. Walter Canonica, David J. Jackson, Parameswaran Nair, Roland Buhl, Johann Christian Virchow
Pages: 1664 - 1668 - I have taken my umbrella, so of course it does not rain(2012)
Authors: DS Postma, Guy Brusselle, A Bush, JW Holloway
Pages: 88 - 89 - Blood eosinophils and smoking history affect outcome with high dose N-acetylcysteine treatment in COPD(2017)Volume: 50
Authors: Alberto Papi, Guy Brusselle, Francesco Sergio, Marco Pannacci, Jinping Zheng, Gerard Criner
Number of pages: 1